ÂÜÀòÂÒÂ×

Nataša Jovic is the Vice President of Commercial at Retinai. Nataša has over 15 years of experience in commercialization strategy and development in the biotech and pharmaceutical industry. Prior to joining Retinai, they were the Senior Director of the Biomarker Health Group at Microbiome Insights Inc., leading commercialization strategy and development for a biomarker testing platform. Nataša has also held senior marketing positions at Notal Vision and QLT Inc., where they were responsible for strategic and brand development, as well as commercialization efforts including digital marketing initiatives. In addition, they have served as a Principal at NJ2M Consulting, providing strategic and operational marketing services to clients in the retina and other therapeutic areas. Nataša began their career in commercial development at Augurex Life Sciences Corp., where they managed commercial planning efforts, including the regulatory pathway for launching an in-vitro diagnostic in rheumatoid arthritis. Nataša holds a Bachelor of Science in Biology from the University of British Columbia.

Nataša Jovic has an MBA in Biotechnology from Simon Fraser University's Segal Graduate School of Business.

Nataša Jovic reports to Carlos Ciller, Co-Founder & CEO. Nataša Jovic works with Sandro De Zanet - Co-Founder, Head of Research, Aunia Grogan - VP, Business Development, and Angela Higgs - VP, Human Resources.